Active replication — ongoing trial, registry, or meta-analysis.
Recent follow-up analyses of EMBOLISE are confirming the original effect size in real-world data.
Your position — does this noeme still stand given current evidence?
0% (impossible)
50%
100% (certain)
Proper-scoring-rule preview
Your position is kept on this device until you sign in.
Evidence stream
1 event · 0 snapshots
Registry data
Apr 18, 2026
Expert reactions · 0
Sign in to post a take, cite a related claim, or flag a methodological concern.
No reactions yet. Be the first expert to post a take, cite a related claim, or flag a methodological concern.
Source publication
A Study of the Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System In the Treatment of Subacute and Chronic Subdural HEmatoma (EMBOLISE)
Semantically related
Nearest claims in the expert-corpus vector space. Ordered by cosine distance — lower is closer.
0.0808
Recent follow-up analyses of MR CLEAN are confirming the original effect size in real-world data.
0.0813
Recent follow-up analyses of DEFUSE-3 are confirming the original effect size in real-world data.
0.0849
Recent follow-up analyses of ESCAPE are confirming the original effect size in real-world data.
0.0905
Recent follow-up analyses of EARLYSTIM are confirming the original effect size in real-world data.
0.0974
Recent follow-up analyses of SWIFT PRIME are confirming the original effect size in real-world data.
0.0992
Recent follow-up analyses of REVASCAT are confirming the original effect size in real-world data.